| Safety and efficacy of single-dose Ad26. COV2. S vaccine against Covid-19 J Sadoff, G Gray, A Vandebosch, V Cárdenas, G Shukarev, B Grinsztejn, ... New England Journal of Medicine 384 (23), 2187-2201, 2021 | 2471 | 2021 |
| Interim results of a phase 1–2a trial of Ad26. COV2. S Covid-19 vaccine J Sadoff, M Le Gars, G Shukarev, D Heerwegh, C Truyers, AM de Groot, ... New England Journal of Medicine 384 (19), 1824-1835, 2021 | 1216 | 2021 |
| Mitochondrial aspartyl-tRNA synthetase deficiency causes leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation GC Scheper, T Van Der Klok, RJ Van Andel, CGM Van Berkel, M Sissler, ... Nature genetics 39 (4), 534-539, 2007 | 535 | 2007 |
| Does phosphorylation of the cap‐binding protein eIF4E play a role in translation initiation? GC Scheper, CG Proud European journal of biochemistry 269 (22), 5350-5359, 2002 | 406 | 2002 |
| Vanishing white matter disease MS van der Knaap, JC Pronk, GC Scheper The Lancet Neurology 5 (5), 413-423, 2006 | 385 | 2006 |
| Phosphorylation of eukaryotic initiation factor 4E markedly reduces its affinity for capped mRNA GC Scheper, B Van Kollenburg, J Hu, Y Luo, DJ Goss, CG Proud Journal of Biological Chemistry 277 (5), 3303-3309, 2002 | 345 | 2002 |
| Translation matters: protein synthesis defects in inherited disease GC Scheper, MS Van Der Knaap, CG Proud Nature Reviews Genetics 8 (9), 711-723, 2007 | 344 | 2007 |
| The mitogen-activated protein kinase signal-integrating kinase Mnk2 is a eukaryotic initiation factor 4E kinase with high levels of basal activity in mammalian cells GC Scheper, NA Morrice, M Kleijn, CG Proud Molecular and cellular biology 21 (3), 743-754, 2001 | 242 | 2001 |
| Regulation of translation initiation factors by signal transduction M Kleijn, GC Scheper, HO Voorma, AAM Thomas European journal of biochemistry 253 (3), 531-544, 1998 | 238 | 1998 |
| Mutant GlialCAM causes megalencephalic leukoencephalopathy with subcortical cysts, benign familial macrocephaly, and macrocephaly with retardation and autism T López-Hernández, MC Ridder, M Montolio, X Capdevila-Nortes, ... The American Journal of Human Genetics 88 (4), 422-432, 2011 | 191 | 2011 |
| Leukoencephalopathy with vanishing white matter: a review M Bugiani, I Boor, JM Powers, GC Scheper, MS van der Knaap Journal of Neuropathology & Experimental Neurology 69 (10), 987-996, 2010 | 188 | 2010 |
| eIF2B-related disorders: antenatal onset and involvement of multiple organs MS Van Der Knaap, CGM Van Berkel, J Herms, R Van Coster, ... The American Journal of Human Genetics 73 (5), 1199-1207, 2003 | 181 | 2003 |
| Final analysis of efficacy and safety of single-dose Ad26. COV2. S J Sadoff, G Gray, A Vandebosch, V Cárdenas, G Shukarev, B Grinsztejn, ... New England Journal of Medicine 386 (9), 847-860, 2022 | 180 | 2022 |
| Astrocytes are central in the pathomechanisms of vanishing white matter S Dooves, M Bugiani, NL Postma, E Polder, N Land, ST Horan, ... The Journal of clinical investigation 126 (4), 1512-1524, 2016 | 133 | 2016 |
| Defective glial maturation in vanishing white matter disease M Bugiani, I Boor, B van Kollenburg, N Postma, E Polder, C van Berkel, ... Journal of Neuropathology & Experimental Neurology 70 (1), 69-82, 2011 | 132 | 2011 |
| MLC1: a novel protein in distal astroglial processes PK Ilja Boor, K de Groot, Q Waisfisz, W Kamphorst, CBM Oudejans, ... Journal of neuropathology and experimental neurology 64 (5), 412-419, 2005 | 129 | 2005 |
| The N and C termini of the splice variants of the human mitogen-activated protein kinase-interacting kinase Mnk2 determine activity and localization GC Scheper, JL Parra, M Wilson, B Van Kollenburg, ACO Vertegaal, ... Molecular and cellular biology 23 (16), 5692-5705, 2003 | 125 | 2003 |
| Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation: clinical and genetic characterization and target for therapy L van Berge, EM Hamilton, T Linnankivi, G Uziel, ME Steenweg, ... Brain 137 (4), 1019-1029, 2014 | 120 | 2014 |
| Glia-specific activation of all pathways of the unfolded protein response in vanishing white matter disease B Van Kollenburg, J Van Dijk, J Garbern, AAM Thomas, GC Scheper, ... Journal of Neuropathology & Experimental Neurology 65 (7), 707-715, 2006 | 116 | 2006 |
| Safety and immunogenicity of the Ad26. COV2. S COVID-19 vaccine candidate: interim results of a phase 1/2a, double-blind, randomized, placebo-controlled trial J Sadoff, ML Gars, G Shukarev, D Heerwegh, C Truyers, AM de Groot, ... MedRxiv, 2020.09. 23.20199604, 2020 | 114 | 2020 |
